Melanotan 2 Community Reports
What do these badges mean?
Evidence tier
- AHuman-validated — Human trials showing positive results and good safety.
- BAnimal-grade — No human trials yet, but solid animal/preclinical evidence of effect and safety.
- CAnecdotal — No human or animal trials — only anecdotal/observational reports.
- DInsufficient evidence — No or insufficient evidence (encyclopedia only — never recommended by the builder).
Safety light
- 🟢 Green — Only mild, manageable side effects; reasonable safety data.
- 🟡 Yellow — Needs active management, has a meaningful contraindication/interaction, or has thin long-term data.
- 🔴 Red — Risk of a hospital-level event — treat with serious caution.
Browse-only — not on the protocol builder's curated shortlist, so the builder won't recommend it.
How can it help me?
Wiki article — community perspective
Companion raw digest:
Evidence tier: throughout
Last updated: 2026-07-10
Cross-refs: *peptides/melanotan-1* · *peptides/pt-141*
The full evidence — every human, animal, and lab study, graded — is one tap away: use the See the deeper science → toggle at the top.
Typical dosing
Talk to your medical provider before starting any protocol. That said, here are the doses most people commonly use — shared for educational purposes so you can have an informed conversation. These peptides are sold for research use only and are not FDA-approved drugs, and this isn't medical advice.
What should I avoid combining — and what's synergistic?
Melanotan 2 Community Reports doesn't have a dedicated stacking protocol in our notes — the interactions that matter most are in the safety section above. For how people combine it with other peptides, the deeper-science view has the full detail.
How can I buy this?
We don't have a verified affiliate source for Melanotan 2 Community Reports yet, so there's no coupon or vendor link here — we won't point you to a seller we haven't vetted. When buying any research-use-only peptide, the single biggest variable is the supply chain: insist on a vendor that publishes third-party Certificates of Analysis (COAs) confirming identity and >99% purity. Working with a peptide-literate clinician is one solid route — see our provider directory — or check back as our verified sources list grows.
Wiki article — community perspective
Companion raw digest:
Evidence tier: throughout
Last updated: 2026-07-10
Cross-refs: *peptides/melanotan-1* · *peptides/pt-141*
Who reports the strongest results
Users who specifically want the fastest, deepest possible tan and can tolerate significant GI side effects and unwanted sexual effects during the loading phase. MT-II is not a beginner peptide and the community treats it as such. Results are real and dramatic — the cost is a demanding initial side effect profile.
What the community actually says
The tan result
“Dominican dark” is the community benchmark phrase. MT-II produces a level of melanin saturation not achievable by even naturally tan-skinned people with UV alone. Tan develops within 7–12 days with UV exposure — roughly 2× faster than MT-I.
The community is honest that this result comes with trade-offs. Approximately 35% of users who start MT-II don’t complete their intended protocol (vs ~90% for MT-I), primarily due to nausea and sexual side effects.
Sexual effects — the secondary activation
MC4R receptor activation produces spontaneous erections (~60% of male users during loading) and libido increase (near-universal, both sexes).
Community framing depends on the user:
- For those who want both tanning and sexual effects: MT-II is valued as a dual-effect peptide
- For those who want tanning only: bedtime injection + starting at 0.25 mg minimizes intrusion; effects reduce substantially at maintenance doses
- For women: many prefer MT-I specifically to avoid these effects
Safety signals — what this community takes seriously
Mole monitoring (universal protocol)
Every substantive MT-II thread addresses this. Community-developed standard:
- Full-body mole photography before first dose
- Monthly review during use for changes in size, shape, or border pattern (darkening alone is expected and not a signal)
- Any rapidly changing lesion: dermatologist regardless of MT-II status
- History of melanoma, many atypical nevi, or family history: consult dermatologist before using
The 16-year-old dysplastic nevus account — documented in community: a teenager using MT-II had a mole change sufficiently to prompt biopsy; pathology returned dysplastic nevus. Not melanoma, but a changed atypical mole. This case circulates in every dermatology-adjacent MT-II thread.
Priapism — documented case
A PMC-published case documents priapism (prolonged, painful erection requiring surgical intervention) in a 55-year-old man after MT-II use. Community standard: if erection persists beyond 4 hours, this is a medical emergency.
Protocol as used by the community
First use: 0.25 mg SubQ — always start low for nausea tolerance
Loading: Titrate to 0.5–1 mg every 2–3 days with UV exposure; bedtime injection is near-universal community advice
Maintenance: 0.5–1 mg every 5–10 days once tan established; UV less critical once melanin is built
Bedtime injection consensus: Inject before bed. Nausea peaks 30–90 minutes post-injection and passes while sleeping. Sexual effects are also neutralized during sleep. This single practice dramatically improves tolerability.
Side effects
| Effect | Pattern |
|---|---|
| Nausea | 50–90% during loading; diminishes with adaptation; managed with bedtime timing and famotidine prophylaxis |
| Spontaneous erections | ~60% male users during loading; reduces at maintenance |
| Flushing | Common; accompanies nausea onset |
| Mole darkening | Universal; expected; requires monitoring |
| Priapism | Rare; documented; > 4 hours = medical emergency |
| Appetite suppression | Incidental; MC4R effect |
MT-II vs MT-I — when each is the better choice
| Criteria | MT-II | MT-I |
|---|---|---|
| Tan speed | 7–12 days | 18–28 days |
| Tan depth | Deepest possible | Natural, gradual |
| Sexual effects | Yes (MC4R) | No |
| Nausea | 50–90% | Mild |
| Completion rate | ~35% | ~90% |
| Safer for women? | Less preferred | Preferred |
| Safer overall? | More complex | Cleaner profile |
Cross-references
*peptides/melanotan-1*— the safer alternative for tanning without sexual effects*peptides/pt-141*— the sexual activation peptide derived from MT-II; sexual effects only, no tanning at standard doses
Commercial note
Melanotan II is available through Alyve — use code OHM-15 at checkout for 15% off.
Note: Given the skin monitoring requirements, users are encouraged to establish a dermatology baseline before starting any melanocyte-stimulating peptide.